Difference between revisions of "Factor IX, recombinant, Fc fusion protein (Alprolix)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Warner-admin moved page Factor IX, recombinant, FC fusion protein (Alprolix) to Factor IX, recombinant, Fc fusion protein (Alprolix) without leaving a redirect) |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 8: | Line 8: | ||
# Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, Josephson NC, Perry D, Manco-Johnson MJ, Apte S, Baker RI, Chan GC, Novitzky N, Wong RS, Krassova S, Allen G, Jiang H, Innes A, Li S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Nugent K, Vigliani G, Brennan A, Luk A, Pierce GF; B-LONG Investigators. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med. 2013 Dec 12;369(24):2313-23. Epub 2013 Dec 4. [http://www.nejm.org/doi/full/10.1056/NEJMoa1305074 link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24304002 PubMed] | # Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, Josephson NC, Perry D, Manco-Johnson MJ, Apte S, Baker RI, Chan GC, Novitzky N, Wong RS, Krassova S, Allen G, Jiang H, Innes A, Li S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Nugent K, Vigliani G, Brennan A, Luk A, Pierce GF; B-LONG Investigators. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med. 2013 Dec 12;369(24):2313-23. Epub 2013 Dec 4. [http://www.nejm.org/doi/full/10.1056/NEJMoa1305074 link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24304002 PubMed] | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Inherited coagulopathy medications]] | [[Category:Inherited coagulopathy medications]] | ||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
Revision as of 23:12, 13 June 2018
To be completed
Also known as
- Brand name: Alprolix
References
- Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, Josephson NC, Perry D, Manco-Johnson MJ, Apte S, Baker RI, Chan GC, Novitzky N, Wong RS, Krassova S, Allen G, Jiang H, Innes A, Li S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Nugent K, Vigliani G, Brennan A, Luk A, Pierce GF; B-LONG Investigators. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med. 2013 Dec 12;369(24):2313-23. Epub 2013 Dec 4. link to original article PubMed